By WILL WEISSERT, Associated Press WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription…
Read more AstraZeneca agrees to lower drug prices for Medicaid under Trump administration dealDoctors may soon have a new way to treat high blood pressure, even among people for whom medicines haven’t worked well in the past.Baxdrostat, an experimental medicine made…
Read more There may soon be a new approach to treat hard-to-control high blood pressureSciCheck Digest A rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it…
Read more Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 VaccineBristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. Continue reading this article with a Barron’s subscription. View Options Source link
Read more Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 BillionI am not an anti-vaxxer but… On 29 April 2021, Lisa Shaw, a clever, sensible, creative, mischievous, award-winning presenter at BBC Radio Newcastle, had her first Covid vaccination.…
Read more The real Covid jab scandal is finally emergingBy Anthony O. Goriainoff AstraZeneca said Thursday that its and MSD’s Lynparza cancer treatment had been approved in the U.S. for the treatment of metastatic castration-resistant prostate cancer,…
Read more AstraZeneca Says US Approved Lynparza as a Prostate Cancer TreatmentNearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime…
Read more Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021, and of…
Read more SII stopped Covishield production in Dec 2021, says CEO Adar Poonawalla
